Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day
Stocks in this Quantisnow insightHealth Care
Historical context for LH
Across the 30 sessions after earlier LH headlines, the stock closed higher 17 times and lower 13 times, with a median move of 1.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | LH | SPY |
|---|---|---|---|
| Sep 8, 2026 | Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials | -0.6% | -0.5% |
| Aug 31, 2026 | Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity | -0.7% | -0.3% |
| Aug 28, 2026 | Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference | -0.4% | -0.2% |
| Aug 24, 2026 | Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings | +0.9% | -0.3% |
| Aug 18, 2026 | Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health | -0.4% | -0.7% |
| Aug 17, 2026 | Labcorp to Host Investor Day on September 10, 2026 | +1.6% | -0.5% |
Quantisnow market dataNYSE
LH
Labcorp Holdings Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical Specialities
Get push alerts for LH
Full LH profile on Quantisnow Follow LH and get a push notification the moment its next story breaks.